Zhejiang Medicine Co., Ltd. (SHA:600216)
China · Delayed Price · Currency is CNY 14.74
+0.39 (2.72%)
Feb 3, 2026, 2:55 PM CST
Zhejiang Medicine Revenue
Zhejiang Medicine had revenue of 2.37B CNY in the quarter ending September 30, 2025, a decrease of -12.37%. This brings the company's revenue in the last twelve months to 8.96B, down -0.81% year-over-year. In the year 2024, Zhejiang Medicine had annual revenue of 9.38B with 20.29% growth.
Revenue (ttm)
8.96B
Revenue Growth
-0.81%
P/S Ratio
1.52
Revenue / Employee
1.54M
Employees
5,815
Market Cap
13.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.38B | 1.58B | 20.29% |
| Dec 31, 2023 | 7.79B | -321.66M | -3.96% |
| Dec 31, 2022 | 8.12B | -1.01B | -11.10% |
| Dec 31, 2021 | 9.13B | 1.80B | 24.60% |
| Dec 31, 2020 | 7.33B | 283.01M | 4.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Hisun Pharmaceutical | 9.84B |
| Shanghai Shyndec Pharmaceutical | 9.36B |
| Guobang Pharma | 5.94B |
| Zhejiang Jingxin Pharmaceutical | 4.00B |
| Porton Pharma Solutions | 3.43B |
| Beijing Foyou Pharma CO.,LTD | 3.42B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 2.72B |
| Wedge Industrial | 1.24B |